TI
EBS icon

Trexquant Investment’s Emergent Biosolutions EBS Stock Holding History

Trexquant Investment’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.75M Sell
447,858
-76,375
-15% -$639K 0.02% 890
2026
Q1 		$4.35M Buy
524,233
+222,544
+74% +$2.3M 0.03% 702
2025
Q4 		$3.73M Sell
301,689
-224,599
-43% -$2.41M 0.03% 728
2025
Q3 		$4.64M Sell
526,288
-25,142
-5% -$196K 0.05% 578
2025
Q2 		$3.52M Buy
551,430
+101,809
+23% +$583K 0.04% 664
2025
Q1 		$2.19M Sell
449,621
-251,896
-36% -$2.09M 0.03% 838
2024
Q4 		$6.71M Buy
701,517
+261,099
+59% +$2.4M 0.08% 406
2024
Q3 		$3.68M Buy
+440,418
New +$4M 0.05% 594
2023
Q2 		– Sell
-62,698
Closed -$650K – 1522
2023
Q1 		$650K Buy
+62,698
New +$758K 0.02% 890
2022
Q4 		– Sell
-30,089
Closed -$632K – 1449
2022
Q3 		$632K Buy
30,089
+14,412
+92% +$401K 0.02% 713
2022
Q2 		$487K Sell
15,677
-32,159
-67% -$1.1M 0.02% 837
2022
Q1 		$1.96M Buy
+47,836
New +$2.11M 0.09% 266
2021
Q4 		– Sell
-14,000
Closed -$701K – 1377
2021
Q3 		$701K Buy
+14,000
New +$848K 0.06% 413
2021
Q2 		– Sell
-3,942
Closed -$366K – 1183
2021
Q1 		$366K Buy
+3,942
New +$404K 0.03% 655
2020
Q4 		– Sell
-17,221
Closed -$1.78M – 1124
2020
Q3 		$1.78M Buy
+17,221
New +$1.86M 0.11% 248
2020
Q2 		– Sell
-8,861
Closed -$513K – 1216
2020
Q1 		$513K Buy
+8,861
New +$511K 0.04% 648
2018
Q1 		– Sell
-10,635
Closed -$494K – 1144
2017
Q4 		$494K Buy
+10,635
New +$448K 0.05% 516
2017
Q1 		– Sell
-6,111
Closed -$201K – 1135
2016
Q4 		$201K Buy
+6,111
New +$183K 0.03% 820
2016
Q2 		– Sell
-10,900
Closed -$396K – 925
2016
Q1 		$396K Buy
+10,900
New +$385K 0.05% 648
2015
Q3 		– Sell
-8,600
Closed -$283K – 1084
2015
Q2 		$283K Sell
8,600
-23,600
-73% -$732K 0.03% 831
2015
Q1 		$926K Buy
+32,200
New +$924K 0.09% 406

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
OHA
Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return

Trexquant Investment's EBS Position: Q2 2026 in Review

Trexquant Investment reduced its Emergent Biosolutions (EBS) stake by 15% in Q2 2026, selling an estimated $639K and leaving 447,858 shares worth $3.75M. The position accounts for 0.02% of the portfolio, ranked #890.

Trexquant Investment first reported a position in EBS in Q1 2015 and has held it in 21 quarters since. The position peaked at $6.71M in Q4 2024. 195 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

  • Trexquant Investment held 447,858 shares of Emergent Biosolutions worth $3.75M as of Q2 2026.
  • Trexquant Investment sold 76,375 Emergent Biosolutions shares in Q2 2026, an estimated $639K.
  • Emergent Biosolutions made up 0.02% of Trexquant Investment's portfolio in Q2 2026, its #890 holding.
  • Trexquant Investment first reported a position in Emergent Biosolutions in Q1 2015 and has held it in 21 quarters since.
  • Trexquant Investment's Emergent Biosolutions position peaked at $6.71M in Q4 2024.
  • 195 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.